SCI Abstract

search
+
Light on nonmotor symptoms in Parkinson’s disease patients: The impact on quality of life
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Mitochondrial rescue in Alzheimer’s disease: Exploring marine-derived compounds for brain metabolism regulation
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Glial molecular signatures as a liquid biopsy marker in Alzheimer’s disease diagnosis
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
TMEM230 and mitochondrial regulation in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Redox bioenergetics of neuronal senescence in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Circadian rhythm, metabolic stress, and Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Redefining Alzheimer’s disease diagnostics in the age of blood-based biomarkers
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Neurofilament light chain (NfL) as a biomarker for neurodegeneration: Protein biology, detection methods, and clinical applications
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Metabolic dysregulation in Alzheimer’s disease: Mechanisms, markers, and therapeutic prospects
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
The clinical utility of blood-based biomarkers of Alzheimer’s disease: Triumphs and pitfalls
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Metabolic therapeutic targets in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Astroglial dysregulation and gliotransmitter imbalance in schizophrenia
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Intestinal microbiota in neurodegeneration and ageing: Mechanisms, pathways, and therapeutic interventions
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Energetic crisis, mitochondrial vulnerability and disruption of lactate shuttle in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Molecular insights of peroxisome proliferator-activated receptor-γ signalling in amyotrophic lateral sclerosis and Huntington’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
From metals to mitochondria: Linking trace elements to energy crisis in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
The microbiota-gut–brain axis in epilepsy: Mechanistic insights and emerging probiotic-based therapeutics
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Therapeutic targeting of brain bioenergetics in Alzheimer’s disease addressing insulin resistance, glucose hypometabolism, and mitochondrial dysfunction
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Neurovascular coupling and energy substrate delivery in Alzheimer’s disease
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Metabolic drivers of Alzheimer’s disease pathogenesis: Impairments in glucose utilization, lipid homeostasis, and alternative substrate metabolism
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, includ...
Chaper One - Typical and atypical clinical presentations
Autoimmune myasthenia gravis (MG) is caused by autoantibodies targeting the neuromuscular junction at the postsynaptic lev...
Chapter Two - Diagnosis of MG and differential diagnoses
The diagnostic workup for myasthenia gravis extends beyond the objective evaluation of skeletal muscle fatigue during neur...
Chapter Three - The clinical evaluation of myasthenia gravis
The most important clue to myasthenia as a possible diagnosis, is the description of muscle fatigability uncovered during ...
Chapter Four - Myasthenia gravis in women
Transient neonatal MG is caused by the transplacental transfer of IgG antibodies from the mother to the fetus, starting in...
Chapter Five - Clinical outcome measures
The World Health Organization defines health as a state of complete physical, mental, and social well-being and not merely...
Chapter Six - Traditional treatments and different geographical approaches
Treatment and clinical research in myasthenia gravis (MG) have had major advances during the past 60 years. The 1930s saw ...
Chapter Seven - Rescue therapy in myasthenia gravis
Myasthenia gravis (MG) is a complex autoimmune neuromuscular disorder marked by fluctuating weakness in voluntary muscles....
Chapter Eight - Novel treatments for myasthenia gravis
Advances in immunology over the last several years have provided insights into the pathophysiology of autoimmune diseases ...
Chapter Nine - Measuring treatment related side effect burden in myasthenia gravis
Myasthenia gravis (MG) treatments are rapidly increasing. Since 2021, the FDA approved 6 new MG therapies including IV and...
Chapter Ten - Exercise and myasthenia gravis
Despite the limited number of studies, evidence consistently supports the safety and benefits of exercise for individuals ...
Load More
format_indent_increase